Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

XPeng (XPEV) Stock on November 16, 2025: Earnings Countdown, Flying Cars and Viral Humanoid Robot

XPeng (XPEV) Stock on November 16, 2025: Earnings Countdown, Flying Cars and Viral Humanoid Robot

XPeng heads into a pivotal week with three intertwined storylines: expectations for booming third‑quarter earnings, a viral humanoid robot that has people arguing whether it’s even real, and fresh headlines that China has started trial production of flying cars with XPeng’s AeroHT subsidiary already sitting on thousands of pre‑orders. GuruFocus+1
16 November 2025
···
American Bitcoin Corp (ABTC) in Focus: Scaramucci’s $100M Bet, Q3 Profit and 4,004 BTC Reserve – Nov. 16, 2025

American Bitcoin Corp (ABTC) in Focus: Scaramucci’s $100M Bet, Q3 Profit and 4,004 BTC Reserve – Nov. 16, 2025

American Bitcoin Corp – the Trump‑family‑backed Bitcoin mining and accumulation company – is back at the center of the crypto spotlight today after multiple reports confirmed that the Scaramucci family has invested over $100 million into the firm, part of a $220 million pre‑IPO funding round completed before its Nasdaq debut. CryptoRank+2Markets+2
16 November 2025
··
Alembic Raises $145M for Causal AI as Accenture and Jeffrey Katzenberg’s WndrCo Back Marketing’s New Supercomputer

Alembic Raises $145M for Causal AI as Accenture and Jeffrey Katzenberg’s WndrCo Back Marketing’s New Supercomputer

San Francisco–based AI startup Alembic Technologies has closed a $145 million Series B round to scale its causal AI platform and build what it claims is one of the fastest privately owned supercomputers in the world. The funding is led by Prysm Capital and Accenture, with participation from Jeffrey Katzenberg’s WndrCo, Silver Lake Waterman, Liquid 2 Ventures, NextEquity and others.WebProNews+3The Wall Street Journal+3Venturebeat+3
16 November 2025
···
Agentic AI Hits an Inflection Point: Enterprise ROI, Software Winners and New Risks – November 14, 2025

Agentic AI Hits an Inflection Point: Enterprise ROI, Software Winners and New Risks – November 14, 2025

As of November 14, 2025, “agentic AI” – AI systems that pursue goals autonomously across tools and data – has clearly become the enterprise buzzword of the year. But today’s news flow suggests it’s now more than branding: some companies are finally seeing returns, while others scramble to rebuild their tech stacks and risk controls around AI agents.
14 November 2025
····
Tripadvisor (TRIP) Stock Edges Higher as Mizuho Upgrade Backs Cost Cuts, Viator Merger and AI Pivot – November 14, 2025

Tripadvisor (TRIP) Stock Edges Higher as Mizuho Upgrade Backs Cost Cuts, Viator Merger and AI Pivot – November 14, 2025

Tripadvisor, Inc. returned to investors’ good graces on Friday after Mizuho upgraded the online travel company and lifted its price target, signaling Wall Street is starting to warm to an aggressive restructuring that includes layoffs, a Viator merger and a deeper bet on AI-powered travel experiences. Investing.com+1
14 November 2025
···
Trump-Backed American Bitcoin Corp (ABTC) Q3 2025 Earnings: Revenue Jumps 453% as BTC Hoard Tops 4,000, But Stock Whipsaws on Bitcoin Crash

Trump-Backed American Bitcoin Corp (ABTC) Q3 2025 Earnings: Revenue Jumps 453% as BTC Hoard Tops 4,000, But Stock Whipsaws on Bitcoin Crash

Trump-linked Bitcoin miner American Bitcoin Corp has just posted its first quarterly profit as a public company, with Q3 2025 revenue surging to $64.2 million and its Bitcoin reserve climbing above 4,000 BTC. Yet despite the blockbuster numbers, ABTC shares swung sharply lower in early trading as Bitcoin itself tumbled below $95,000 in a violent crypto sell-off. PR Newswire+2Finviz+2
14 November 2025
····
1 … 48 49 50 51 52 … 164

Stock Market Today

  • Revolution Medicines (RVMD) Shares Trade at a Premium Despite Robust Gains
    July 25, 2026, 2:47 PM EDT. Revolution Medicines (RVMD) shares have jumped with a 399.2% return over the past year and approximately 6.4x growth in three years, though the stock's valuation is considered steep. With a P/B ratio of 26.8x, Revolution Medicines is well above the Biotech sector's 2.5x average and peer level of 10.3x. The stock meets just 2 out of 6 valuation criteria, indicating a premium linked to its FDA-reviewed drug daraxonrasib and data from its pancreatic cancer trial, along with concerns tied to regulatory risk.